Kezar Life Sciences announces 1-for-10 reverse stock split effective Oct 29, 2024

Kezar Life Sciences, Inc.

Reverse split at 1:10 ratio; shares reduce from 72,962,220 to 7,296,222.
Effective 5:00 p.m. ET Oct 29; trading on split-adjusted basis starts Oct 30.
Split aims to regain Nasdaq minimum bid price compliance of $1.00 per share.
No fractional shares; fractional holders receive rounding up to whole share.
No change to authorized shares, par value, or trading symbol KZR.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Kezar Life Sciences, Inc.: Amended certificate of incorporation to effect a 1-for-10 reverse stock split (effective 2024-10-29).

Change: charter amendment
Effective: 2024-10-29

Exact text from the filing

On October 28, 2024, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment of its Amended and Restated Certificate of Incorporation (the “Charter Amendment”) to effect the Reverse Stock Split. The Charter Amendment will become effective at 5:00 p.m. Eastern Time on October 29, 2024 (the “Effective Time”).

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Kezar Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-117723

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.